Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

Presentation TCT 2016

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Presenter: Tony Das, Koen Deloose, Ehrin J. Armstrong

October 31, 2016

Presentation TCT 2016

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara

October 30, 2016

Presentation TCT 2016

Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History!

Presenter: Manel Sabate, Robert-Jan van Geuns, Sunil V. Rao

October 30, 2016

Presentation TCT 2016

Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role!

Presenter: Manel Sabate, Robert-Jan van Geuns, Eric R. Bates

October 30, 2016

Presentation

Is BMS Implantation Still Justifiable in High Bleeding Risk Patients Undergoing PCI?

Presenter: Sara Ariotti

March 07, 2016

Presentation

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

Presenter: Dean J. Kereiakes

October 22, 2015

Presentation TCT 2015

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent vs BMS in Patients With Coronary Artery Disease at High Risk for Bleeding

Presenter: Philip M. Urban

October 14, 2015

Presentation TCT 2015

DCBs Plus Adjunctive BMS Use: Current Use, Rationale, and Pitfalls

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt

October 12, 2015

Presentation TCT 2015

In Which Patients (if Any) Should BMS Be Used in 2015? Evidence and Common Sense

Presenter: John A. Bittl, E. Magnus Ohman, Marco Valgimigli

October 11, 2015

Presentation

Single-Arterial or Multiarterial CABG vs PCI With DES or BMS for Multivessel CAD

Presenter: RH. Habib

September 23, 2015

Presentation

Improved Outcomes of Elderly Patients Treated With DES vs BMS in Large Coronary Arteries

Presenter: David J. Kruz

July 28, 2015

Presentation

Long-term Safety of DES and BMS

Presenter: T. Palmerini

June 09, 2015

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

Presentation

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

Presenter: T.C. Poerner

December 14, 2014

Presentation

Safety and Effectiveness of DES vs BMS in Saphenous Vein Graft PCI

Presenter: V. Aggarwal

October 23, 2014

Presentation

Impact on In-Hospital Outcomes with DES vs BMS

Presenter: Apurva O. Badheka

October 01, 2014

Presentation TCT 2014

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Huay Cheem Tan

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

Presentation TCT 2014

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Anthony H. Gershlick

September 14, 2014

Advertisement

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History!

Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role!

Is BMS Implantation Still Justifiable in High Bleeding Risk Patients Undergoing PCI?

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent vs BMS in Patients With Coronary Artery Disease at High Risk for Bleeding

DCBs Plus Adjunctive BMS Use: Current Use, Rationale, and Pitfalls

In Which Patients (if Any) Should BMS Be Used in 2015? Evidence and Common Sense

Single-Arterial or Multiarterial CABG vs PCI With DES or BMS for Multivessel CAD

Improved Outcomes of Elderly Patients Treated With DES vs BMS in Large Coronary Arteries

Long-term Safety of DES and BMS

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

Safety and Effectiveness of DES vs BMS in Saphenous Vein Graft PCI

Impact on In-Hospital Outcomes with DES vs BMS

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content